DE60113704D1 - Verwendung einer kombination von nicotinsäuren oder deren derivaten und riboflavin zur herstellung eines arzneimittels zur behandlung von primären kopfschmerzen - Google Patents

Verwendung einer kombination von nicotinsäuren oder deren derivaten und riboflavin zur herstellung eines arzneimittels zur behandlung von primären kopfschmerzen

Info

Publication number
DE60113704D1
DE60113704D1 DE60113704T DE60113704T DE60113704D1 DE 60113704 D1 DE60113704 D1 DE 60113704D1 DE 60113704 T DE60113704 T DE 60113704T DE 60113704 T DE60113704 T DE 60113704T DE 60113704 D1 DE60113704 D1 DE 60113704D1
Authority
DE
Germany
Prior art keywords
treatment
migraine
riboflavin
combination
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60113704T
Other languages
English (en)
Other versions
DE60113704T2 (de
Inventor
Giampiero Valletta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60113704D1 publication Critical patent/DE60113704D1/de
Publication of DE60113704T2 publication Critical patent/DE60113704T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60113704T 2000-08-07 2001-07-20 Verwendung einer kombination von nicotinsäuren oder deren derivaten und riboflavin zur herstellung eines arzneimittels zur behandlung von primären kopfschmerzen Expired - Lifetime DE60113704T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2000RM000448A IT1320776B1 (it) 2000-08-07 2000-08-07 Composizione farmaceutica a base di un'associazione vitaminica per laterapia delle cefalee primarie
ITRM000448 2000-08-07
PCT/IT2001/000388 WO2002011731A2 (en) 2000-08-07 2001-07-20 Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches

Publications (2)

Publication Number Publication Date
DE60113704D1 true DE60113704D1 (de) 2006-02-09
DE60113704T2 DE60113704T2 (de) 2006-07-06

Family

ID=11454879

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60113704T Expired - Lifetime DE60113704T2 (de) 2000-08-07 2001-07-20 Verwendung einer kombination von nicotinsäuren oder deren derivaten und riboflavin zur herstellung eines arzneimittels zur behandlung von primären kopfschmerzen

Country Status (13)

Country Link
US (1) US7456291B2 (de)
EP (1) EP1318815B1 (de)
JP (1) JP2004505919A (de)
KR (1) KR100816140B1 (de)
CN (1) CN100408038C (de)
AT (1) ATE305305T1 (de)
AU (2) AU7667201A (de)
CA (1) CA2417758C (de)
DE (1) DE60113704T2 (de)
ES (1) ES2248362T3 (de)
IT (1) IT1320776B1 (de)
RU (1) RU2274448C2 (de)
WO (1) WO2002011731A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2124907B1 (de) 2007-03-19 2018-05-30 Vita Sciences, Llc Transdermales pflaster und verfahren zur verabreichung von vitamin b12
WO2012103377A1 (en) 2011-01-26 2012-08-02 Nico Worldwide, Inc. Remedy for migraine headache
AU2021260956A1 (en) * 2020-04-22 2022-11-17 Linzy O. Scott Iii Treatment of conditions associated with thyroid hormone

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2480517A (en) * 1946-03-02 1949-08-30 Merck & Co Inc Fused riboflavin-amide
DE1670342A1 (de) * 1966-04-23 1970-10-29 Albert Ag Chem Werke Verfahren zur Herstellung eines neuen nikotinsauren Salzes
AU587863B2 (en) * 1985-10-07 1989-08-31 Basf Aktiengesellschaft Vitamin-containing granules and production thereof
US4973467A (en) * 1989-10-13 1990-11-27 Natrol, Inc. Dietary supplement for adults
US5571441A (en) * 1994-11-01 1996-11-05 The Procter & Gamble Company Nutrient supplement compositions providing physiologic feedback
GB9601398D0 (en) 1996-01-24 1996-03-27 Piper Edwina M Composition
US6017946A (en) * 1997-10-08 2000-01-25 Posner; Robert Serotonin containing formulation for oral administration and method of use
US6068999A (en) 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
IT1306141B1 (it) * 1999-05-17 2001-05-30 Giampiero Valletta Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.

Also Published As

Publication number Publication date
US20030181459A1 (en) 2003-09-25
AU7667201A (en) 2002-02-18
JP2004505919A (ja) 2004-02-26
ES2248362T3 (es) 2006-03-16
CN100408038C (zh) 2008-08-06
KR20030022352A (ko) 2003-03-15
CN1635893A (zh) 2005-07-06
WO2002011731A2 (en) 2002-02-14
EP1318815B1 (de) 2005-09-28
CA2417758A1 (en) 2002-02-14
US7456291B2 (en) 2008-11-25
DE60113704T2 (de) 2006-07-06
RU2274448C2 (ru) 2006-04-20
ITRM20000448A0 (it) 2000-08-07
ATE305305T1 (de) 2005-10-15
ITRM20000448A1 (it) 2002-02-07
WO2002011731A3 (en) 2002-08-15
IT1320776B1 (it) 2003-12-10
EP1318815A2 (de) 2003-06-18
CA2417758C (en) 2009-09-08
KR100816140B1 (ko) 2008-03-21
AU2001276672B2 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
CY1123084T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
EA200300248A1 (ru) Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
YU45403A (sh) Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida
BG103964A (en) SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS
HRP20080664A2 (en) Substituted pyridine herbicides
RS50360B (sr) Farmaceutske formulacije derivata platine
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
NO20050514L (no) Sammensetning og antiviral aktivitet til substituerte azaindoloksoeddikpiperazinderivater
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
EA200400223A1 (ru) Новые производные 2h-пиридазин-3-она, фармацевтические композиции, содержащие эти производные, и способ получения активного ингредиента
ATE231501T1 (de) Phenyldihydrobenzofurane
NO992282D0 (no) Benzonaftyridiner som bronkialterapentika
DE69905878D1 (de) Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen
IL165217A (en) Pesticidal pyridinecarboxamide derivatives, process for their preparation, pesticidal compositions comprising them and use thereof in the preparation of pesticidal compositions
ES2189871T3 (es) Ciclohexil-dihidro-benzofuranos.
MA27232A1 (fr) Derives d'acide n-benzoylureidocinnamique, leurs procedes de preparation et leurs utilisations
DE60108626D1 (de) Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b] pyridinen als cyclin-abhängige kinase-hemmer
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
FR2804286B1 (fr) Utilisation de derives de polyaminoacides comme agents conservateurs, compositions les comprenant et procede de conservation les utilisant
DE60213802D1 (de) Cak inhibitoren und deren verwendungen
DE60113704D1 (de) Verwendung einer kombination von nicotinsäuren oder deren derivaten und riboflavin zur herstellung eines arzneimittels zur behandlung von primären kopfschmerzen
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
NO20053876D0 (no) Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav
CY1106472T1 (el) Η χρηση των παραγωγων υδροξυπυριδονης στην επουλωση πληγων
IL153182A0 (en) Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv

Legal Events

Date Code Title Description
8364 No opposition during term of opposition